Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec 16;8(12):e81629.
doi: 10.1371/journal.pone.0081629. eCollection 2013.

Ongoing pregnancy rates in women with low and extremely low AMH levels. A multivariate analysis of 769 cycles

Alon Kedem  1 , Jigal Haas  1 , Liat Lerner Geva  2 , Gil Yerushalmi  1 , Yinon Gilboa  1 , Hanna Kanety  3 , Mirit Hanochi  3 , Ettie Maman  1 , Ariel Hourvitz  1
Affiliations

Ongoing pregnancy rates in women with low and extremely low AMH levels. A multivariate analysis of 769 cycles

Alon Kedem et al. PLoS One. .

Abstract

Background: The ideal test for ovarian reserve should permit the identification of women who have no real chance of pregnancy with IVF treatments consequent upon an extremely reduced ovarian reserve. The aim of the current study was to evaluate pregnancy rates in patients with low AMH levels (0.2-1 ng/ml) and extremely low AMH levels (<0.2 ng/ml) and to determine the cumulative pregnancy rates following consecutive IVF treatments.

Methods: We conducted an historical cohort analysis at a tertiary medical center. Serum AMH levels were measured at initial clinic visit and prior to all following treatment cycles in 181 women (769 cycles) with an initial AMH level ≤1 ng/ml, undergoing IVF-ICSI. Main outcome measures were laboratory outcomes and pregnancy rates.

Results: Seventy patients undergoing 249 cycles had extremely low AMH levels (≤0.2 ng/ml), whereas 111 patients undergoing 520 cycles had low AMH levels (0.21-1.0 ng/ml). Number of oocytes retrieved per cycle, fertilized oocytes and number of transferred embryos were significantly lower in the extremely low AMH levels group compared to the low AMH levels (P<0.003). Crude ongoing pregnancy rates were 4.4% for both groups of patients. Among 48 cycles of women aged ≥42 with AMH levels of ≤0.2 ng/ml no pregnancies were observed. But, in patients with AMH levels of 0.2-1.0 ng/ml, 3 ongoing pregnancies out of 192 cycles (1.6%) were observed. However, in a multivariate regression analysis adjusted for age and cycle characteristics, no significant differences in ongoing pregnancy rates per cycle between the two groups were evident. Cumulative pregnancy rates of 20% were observed following five cycles, for both groups of patients.

Conclusions: Patients with extremely low AMH measurements have reasonable and similar pregnancy rates as patients with low AMH. Therefore, AMH should not be used as the criterion to exclude couples from performing additional IVF treatments.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Cumulative ongoing pregnancy rates for patients with AMH level of 0.2–1 ng/ml or ≤0.2 ng/ml.
See this image and copyright information in PMC

References

    1. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB (2006) A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 12: 685–718. - PubMed
    1. Nelson SM (2013) Biomarkers of ovarian response: current and future applications. Fertil Steril 99: 963–969. - PubMed
    1. La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, et al. (2007) Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod 22: 766–771. - PubMed
    1. Singer T, Barad DH, Weghofer A, Gleicher N (2009) Correlation of antimullerian hormone and baseline follicle-stimulating hormone levels. Fertil Steril 91: 2616–2619. - PubMed
    1. Nakhuda GS, Chu MC, Wang JG, Sauer MV, Lobo RA (2006) Elevated serum mullerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization. Fertil Steril 85: 1541–1543. - PubMed